In iPSCs, the strongest reaction was the tumor-proliferation signature of MKI67+ progenitor cells, while the weakest reactions were the TGFB pathway and the cellular response to hypoxia of nerve cells (Figure 6B). Here, MKI67 is linked to neoplasm.